NVCBR collaborators find disturbed immune function in those with autism spectrum disorder (ASD), consistent with a growing body of evidence supporting immunopathology in ASD.
Decreased Numbers of CD57+CD3− Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder